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Abstract
Lipophilic marine toxins (LMTs) are a group of marine toxins which in recent 
years have been consistently identified in the vast majority of shellfish worldwide. 
One of their main characteristics is having a latitudinal variability and an assimila-
tion/retention specific for each species. LMTs consist of four important groups: 
okadaic acid group (OA-group), pectenotoxin group (PTX-group), azaspiracid 
group (AZA-group) and yessotoxin group (YTX-group). These groups have differ-
ent chemical structures, which has generated an important challenge to establish 
analytical techniques to identify all toxic analogues from the same toxic matrix. 
Likewise, in the aquatic environment, shellfish represent the best bio-indicator 
model that allows for the establishment of levels of toxicities related to LMTs. In 
this chapter, the evolution for detection of LMTs from mouse bioassay (MBA), 
enzymatic assays (PP2a), and analytical techniques, such as liquid chromatography 
tandem-mass spectrometry (LC-MS/MS), are described. These analytical advances 
have allowed us to determine and identify the characteristic profiles of LMTs 
produced by marine microalgae, including the prevalence and biotransformation of 
LMTs in the different endemic species. It is worth mentioning that these techniques 
have favoured the updating of numerous sanitary standards and the definition of 
the most appropriate technique for the detection of LMTs in shellfish and endemic 
species.
Keywords: lipophilic marine toxins, AZA-group, OA-group, PTX-group,  
YTX-group, shellfish, mouse bioassay, protein phosphatase, liquid chromatographic, 
risk assessment
1. Introduction
Harmful algal blooms (HABs) consist of a group of cells (dinoflagellates, cyano-
bacteria and diatoms) that, under the interaction of multiple environmental factors 
such as luminous intensity, temperature, nutrients and salinity, among others, can 
increase their cell density when compared to the base population of cells present 
in the sea, lakes and rivers. At the same time, these HABs are associated with the 
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capacity to produce powerful toxins that may affect the marine life of fish, marine 
larvae, mammals and people [1, 2].
Over the past few years, HABs have been showing a greater frequency and 
intensity [3–5]. Among the factors that have been proposed to be related to this 
global increase in HABs (Figure 1), the following are highlighted: eutrophication 
of coastal waters as a result of increased aquaculture and/or from fertilisers derived 
from agriculture, activities linked to urbanisation, climate change, transport of 
ballast water from ships and/or the transfer of shellfish populations from already 
contaminated areas [6, 7].
HABs associated with the number of toxin-producing cells can vary consider-
ably during the year. Periods of exponential growth may occur, which is perceived 
as a bloom, during changes in weather conditions, water temperature, turbulence 
(waves), water salinity, and concentration of dissolved nutrients [8–10]. These 
environmental factors can directly affect the variability and concentration of toxins 
produced by each of the species involved in a bloom [7, 9, 11].
Due to the above, it is possible to establish that environmental conditions may 
favour the algal blooms of more than one toxin-producing microalgae, thus generat-
ing simultaneous harmful processes in the shellfish and lake ecosystems. Therefore, 
aquatic organisms can assimilate more than one toxic variety in their tissues, 
expanding the toxic effects to the living organisms in the system [10, 12, 13].
The main organisms affected by HABs are aquatic filter-feeder organisms, 
such as bivalves, which are characterised by having a high water filtration 
capacity (20 L h−1) which allows them to accumulate high levels of nutrients, in 
addition to the accumulation of toxic phytoplankton in their tissues. All these 
processes are variable and dependent on endemic species in different areas of the 
planet [2, 14].
Several studies have provided strong scientific evidence stating that the different 
endemic species of bivalves identified worldwide are capable of exercising natural 
control of phytoplankton in coastal waters. This control process is characterised 
by two stages: (a) Filtration stage: this involves the accumulation of harmful dino-
flagellates and their toxins in the digestive glands of shellfish (hepatopancreas); 
(b) Distribution stage: this involves the distribution of toxins to non-visceral tis-
sues of shellfish, such as the mantle, gills, foot and adductor muscle [15–17]. This 
Figure 1. 
Geographic distribution of harmful algal blooms associated with the identification of lipophilic marine toxins 
[1, 3, 5, 14].
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distribution to the non-visceral tissues favours the variation of the toxic profiles 
assimilated in the first stage, through biotransformation pathways that involve 
enzymatic and non-enzymatic processes [18, 19]. These processes are enhanced by 
the transfer of toxins through the trophic chain, where an accumulation of toxins 
with very different profiles is produced in each of the marine organisms involved 
in the process (zooplankton and whales) [15, 20, 21]. The above mentioned stages 
are characterised by not causing any apparent damage to the structures and cellular 
composition of shellfish and bivalves, allowing these toxic compounds to remain in 
the digestive glands for prolonged periods (months) [22].
The prediction of HABs is very difficult, as there are a number of factors to be 
considered, such as physical parameters (meteorological and weather parameters, 
temperature, wind and light conditions, as well as hydrography), chemical param-
eters (nutrient variability, eutrophication, oxygen availability, anthropogenic pollu-
tion and ocean acidity) and biological parameters (evolution of algal communities, 
grazing and interaction of parasitic microorganisms or viruses) [7].
However, the knowledge of background information related to the temporal and 
geographical distribution of HAB-producing species is important for the under-
standing of the problems at a global level [23].
Consumption of seafood products, mainly filter-feeding shellfish contaminated 
with high amounts of phycotoxins in its visceral (digestive glands) and non-visceral 
(mantle, gills and foot) tissues, tends to produce severe intoxication when con-
sumed by humans [24]. The number of people intoxicated with these phycotoxins 
worldwide has reached an average of 60,000 cases per year. This, in turn, produces 
a large impact on the local economy due to its negative effects on tourism, recre-
ation, and miticulture and aquaculture industries [25, 26]. In Europe, the losses 
estimated every year in tourism as a result of HABs are approximately € 700 million 
and about € 116 million in miticulture [1, 4, 27]. Likewise, in order to prevent 
poisoning caused by the consumption of shellfish or hydrobiological organisms 
contaminated with phycotoxins, international entities have developed regulations, 
legislation and follow-up programs for these HABs [28–31].
1.1 Lipophilic marine toxins
Marine toxins are categorised into different groups, which are characterised by 
different chemical structures and different mechanisms of toxicity [32]. These groups 
can be produced by the same or by different species of marine microalgae [31].
Within these groups of toxins, lipophilic marine toxins (LMTs), formed by the 
following groups, are noted: okadaic acid- (OA), pectenotoxin- (PTX), yessotoxin- 
(YTX) and azaspiracid- (AZA) group.
1.1.1 Okadaic acid group (OA-group)
The OA-group consists of chemical structures formed by transfused polyethers 
that at its polar head have a carboxylic acid. The toxins making up this group are 
called: okadaic acid (OA), dinophysistoxin-1 (DTX-1, 35-R-methyl-OA), dinophy-
sistoxin-2 (DTX-2, 31-demethyl-35-S-methyl-OA) and dinophysistoxin-3 (DTX-3, 
acyl derivatives of OA, DTX-1 and DTX-2) (Figure 2). The OA-group stand out for 
being potent inhibitors of 1, 2A and 3 serine/threonine protein phosphatases (PP1, 
PP2a and PP3) [33, 34].
The consumption of shellfish contaminated with this group of toxins produces 
the medical condition called diarrhoeic shellfish poisoning (DSP), which is charac-




At the beginning of the 1990s, this group of toxins was also formed by the PTX, 
YTX and AZA groups, since the process of extraction and evaluation of toxins in 
bivalves did not differentiate the toxic groups involved in the HABs processes. Thus, 
the toxic symptoms detected in people were associated with diarrhoeic shellfish 
poisoning (DSP). Subsequently, the use of analytical processes established that this 
group was made up of multiple toxins, which had differences from a chemical and 
toxicological point of view, so that each type of toxin was excluded from the OA 
group and classified as PTX, YTX and AZA groups [28, 35, 36].
OA-group is present in both planktonic and epibenthic dinoflagellates of the genera 
Dinophysis and Prorocentrum, where the species Dinophysis acuminata, Dinophysis 
acuta, Dinophysis caudata, Dinophysis fortii, Dinophysis miles, Dinophysis ovum, 
Dinophysis sacculus, Dinophysis rotundata, Dinophysis tripos and Prorocentrum lima, 
Prorocentrum belizeanum, Prorocentrum concavum and Prorocentrum hoffmannianum 
(Table 1) are highlighted [4]. The densities of the dinoflagellates associated with 
OA-group correspond to <104 L−1 cells, with a relative abundance of <103 L−1 cells [37].
The variability of the toxic profile identified in OA-group producing dinoflagel-
lates depends, to a large extent, on the species involved and on the global distribution 
in which the blooms are identified (Figure 1). The variability of the toxin content 
detected in cells of Dinophysis acuta ranges between 0 and 40 OA pg. cell−1, 0–0.02 
DTX-1 pg. cell−1 and 0.3–0.6 DTX-2 pg. cell−1, while for Dinophysis acuminata, it is 
0–160 OA pg. cell−1, 0–7.8 DTX-1 pg. cell−1 and 0–169 DTX-2 pg. cell−1 [38].
At present, data on the chronic effects of OA in animals or humans have been 
insufficient to determine the Tolerable Daily Intake (TDI). However, a Lowest 
Observed Adverse Effect Level (LOAEL) corresponding to 50 μg OA equivalent 
per person has been established, equivalent to ≈0.8 μg OA kg−1 of body weight for 
adults, and a No Observed Adverse Effect Level (NOAEL) corresponding to ≈0.3 μg 
OA equivalents kg−1 b.w. [14].
Considering the lipophilicity of the toxins that make up this group, they are 
easily accumulated in the tissues of the filter-feeding marine organisms that feed 
on HABs, spreading quickly to their predators in the food chain [13]. Moreover, 
depending on the species of molluscs contaminated with the OA-group and 
their natural clearance, the OA-group toxins tend to be chemically modified in 
the visceral tissues of the molluscs. In this way, OA, DTX-1 and DTX-2 can be 
esterified by fatty acids of variable length (C7-C22) in the hydroxyl group (–OH) 
present in carbon 7 of the structure of toxins (Figure 2), palmitic acid (C16:0) 
Figure 2. 
Chemical structures of okadaic acid group and analogues [33, 34].
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being the most prevalent that is identified in this process [39, 40]. This esterifica-
tion results in the toxic structures being named acyl derivatives. However, in their 
first detections, acylation was always associated with DTX-1, acquiring the name 
of dinophysistoxin-3 (DTX-3) [41]. In Chile, palmitic acid accounts for 90% of 
the total fatty acids linked to the esterification of toxins in the OA-group, in which 
7-O-palmitoyl-dinophysistoxin-1 is the most prevalent toxin detected in endemic 
bivalves on the coast of Chile [39, 42]. Although the feasibility of other forms 
of fatty acid derivatives of varying lengths or with different unsaturations may 
produce acyl derivatives of the OA-group, such as C14:0, C16:1, C16:0, C18:1 and 
C18:0 [43–45]. All these 7-O-acyl-OA-group esterified analogues have not been 







Dinophysis miles OA, DTX-1
Dinophysis rotundata OA; PTX-2
Dinophysis infundibulus PTX-2
Dinophysis caudata OA, DTX-1, PTX-2
Dinophysis fortii OA, DTX-1, PTX-3
Dinophysis norvegica OA, DTX-1, PTX-2, PTX-12
Dinophysis acuminata OA, DTX-1; PTX-2; PTX-12






Prorocentrum belizeanum OA, DTX-1
Prorocentrum faustiae OA, DTX-1
Prorocentrum lima OA, DTX-1
Protoperidinium divergens OA, DTX-1
Protoperidinium depressum OA, DTX-1
Protoceratium reticulatum YTX
Gonyaulax spinifera YTX
Lingulodynium poliedrum YTX, homo-YTX, 45-OH-homo-YTX
Protoperidinium crassipes AZA
Echinochlathria sp. AZA-2
Azadinium spinosum AZA-1, -2, -3
Table 1. 
List of dinoflagellate species identified as producer species of lipophilic marine toxins [4, 28, 37, 55, 64, 65, 79, 81].
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The differences observed between the proportions of esterified forms and free 
forms of OA could arise from the genetic differences in bivalves (endemic species), 
since the OA esterification is considered to be an enzymatic mechanism associated 
with the detoxification of bivalves [47]. From a toxic point of view, it has been 
established that the toxicity of endemic species may depend on the variability in the 
lipid content present in the digestive glands, which would favour the retention of 
the toxins, thus explaining its higher toxicity of compartmentalisation if compared 
to non-visceral tissues, such as the mantle or adductor muscle [19, 48, 49].
The symptoms caused by intoxication associated with the consumption of mol-
luscs contaminated with the OA-group are characterised as starting between 1 and 
5 h after the ingestion of contaminated molluscs, symptoms that tend to be reversed 
3 days after the toxic symptoms are initiated [50]. The minimum doses of OA and 
DTX-1 required to produce toxic symptoms in humans have been estimated to be 
40 and 36 μg respectively for a 60 kg person [51]. To date, no deaths of people asso-
ciated with intoxications produced by the OA-group have been recorded. However, 
it has been clearly established that the OA-group is a potent tumour promoter in 
animals [52], thus being associated with the risk of gastric cancer among regu-
lar consumers of contaminated shellfish with toxins of the OA-group [53, 54]. 
Therefore, poisonings associated with the OA-group are a latent problem for both 
public health and the seafood industry [1, 4, 27].
1.1.2 Pectenotoxin group (PTX-group)
Toxins making up the pectenotoxin group (PTXs) correspond to a family of 
toxins of polyether macrolides (Figure 3) produced by the same species that produce 
the toxic forms of the OA-group, such as Dinophysis fortii, Dinophysis acuta, Dinophysis 
acuminata, Dinophysis caudata and Dinophysis norvegica, which are further detected 
in heterotrophic dinoflagellates such as Protoperidinium divergens and Protoperidinium 
depressum (Table 1) [28, 55]. The origin of the name of this group comes from the 
crustacean Patinopecten yessoensis in which it was detected for the first time [33].
For years, the PTX-group was included in the OA-group, since the bioassay tests 
detected the overall toxicity of both groups. Currently, the PTX-group is classified 
as a separate group, based on the biochemical effects on which they act, as this 
group does not inhibit protein phosphatase 2a (PP2a) [14, 56]. To date, no cases of 
intoxication due to consumption of molluscs contaminated with the PTX-group 
have been reported [57].
This group of toxins has been identified in countries such as Ireland, Croatia, 
New Zealand, Portugal, Norway, Japan, Argentina and Chile, showing a direct 
relationship with the areas which have previously been associated with the presence 
of the OA-group (Figure 1) [28, 40, 58, 59].
The toxic profiles detected in dinoflagellates and shellfish tend to be different, 
establishing that a metabolic transformation occurs in the bivalves after the filtra-
tion/assimilation of toxic algae [46]. Filter-feeding bivalves, when accumulating 
this type of toxin (PTX-2) in their digestive glands (hepatopancreas), allow for their 
biotransformation. These biotransformed analogues have been assigned to the seco 
acid (sa) nomenclature, highlighting the identification in bivalves of pectenotoxin-2 
seco acid (PTX-2sa) and 7-epi-pectenotoxins-2-seco-acid (7-epi-PTX-2sa) analogues 
[28, 43]. 7-epi-PTX-2sa, is the result of the interconversion of PTX-2sa to a thermo-
dynamically more stable analogue. In this way, the conversion of PTX-2 to seco-acid 
forms could be considered as a protective effect of detoxification by molluscs [41].
There are about 15 analogues identified and associated with the PTX-group, in 
which the esterified forms of PTX-2sa were the last identified analogues, where 
7Instrumental Methods for Detection of Lipophilic Marine Toxins in Endemic Species…
DOI: http://dx.doi.org/10.5772/intechopen.82438
37-O-acyl ester-PTX-2-sa, 11-O-acyl ester-PTX-2sa and 33-O-acyl ester-PTX-
2sa are noted. All of these analogues were identified in filter-feeding bivalves 
[60–62].
The available toxicological information on the PTX-group is insufficient at 
present due to the lack of toxic analogues required to carry out biological stud-
ies of interest. However, it has been determined that the lethal intraperitoneal 
dose of PTX-2 corresponds to 260 μg kg−1. In addition, the results of the toxicity 
obtained from intraperitoneal (i.p.) administration and oral ingestion of PTX 
in mouse have established that toxicities are comparable, do not produce these 
symptoms of diarrhoea and are only limited to generate histopathological changes 
in the liver, stomach and intestine [60]. Furthermore, it has been determined that 
PTX-2 may potentially be cytotoxic on lung, colon and kidney cell lines. Toxic 
effects are not extrapolated to analogues such as PTX-2-sa and 7-epi-PTX2-sa, 
evidencing the importance of the initial structure of the toxin that generates the 
cytotoxic effects [63].
1.1.3 Yessotoxin group (YTX-group)
Yessotoxin group (YTX-group) corresponds to a group constituted by sulphated 
polyethers (Figure 4), and whose analogues were first identified in the oyster 
Patinopecten yessoensis. Yessotoxin (YTX) is produced by the marine phytoplanktonic 
microalgae Protoceratium reticulatum (Gonyaulax grindley) [64], Lingulodinium 
polyedrum (Gonyaulax polyedra) [35, 65] and Gonyaulax spinifera (Table 1) [35, 66, 67].
Figure 3. 




At present, this group of toxins have been identified in different countries 
worldwide such as New Zealand, Italy, Spain, Norway, Russia, Canada, United 
Kingdom, Japan, Argentina and Chile (Figure 1) [35, 68–70].
Historically, the YTX-group was included in the OA-group, however, this group 
of toxins do not produce diarrhoea in the mouse bioassay, nor do they produce the 
inhibition of the protein phosphatase 2a (PP2a) [71, 72]. Although the precise mode 
of action of the YTX-group is unknown, it has been classified as a potent activator 
of phosphodiesterase [73].
To date, more than 100 natural YTX analogues have been identified and char-
acterised using nuclear magnetic resonance (NMR) and liquid chromatography 
coupled with mass spectrometry (LC-MS). Some of the identified analogues are 
directly related to the producer dinoflagellate, such as norYTX, 41-keto-YTX and 
41a-homo-YTX, while other analogues come from processes of biotransformation 
exerted in the digestive glands of different marine species worldwide that have been 
evaluated and that involve chemical oxidation pathways such as hydroxylations, 
carboxylations, desulfations, methylations and amidations [35, 61]. Thus, ana-
logues such as 45-hydroxy-YTX, homoYTX, 45-hydroxyhomo-YTX, carboxy-YTX, 
Figure 4. 
Chemical structure of yessotoxin-group and their chemical analogues identified in dinoflagellates and bivalve 
molluscs [64, 66].
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carboxyhomo-YTX, 41a-homoYTX, 45-hydroxycarboxy-YTX, and 1-desulphocar-
boxyhomo-YTX are the direct result of biotransformation processes that occur in 
shellfish [28, 46, 74].
The HABs associated with the dinoflagellates producers of the YTX-group are 
characterised by reaching a cell density of 103 L−1 cells, where the production of 
YTXs in dinoflagellates is on average ≈34 pg. cell−1 (0–74 pg. cell−1), where homo-
YTX and YTX are the main toxins forming the profile, whose concentrations are 
variable and dependent on the areas where blooms have been detected [35].
Symptoms caused by intoxication with the YTX-group in humans are unknown, 
because no human poisonings associated with this group have been reported [28]. 
However, the toxic evaluation of YTX in bioassays has determined that an intraperi-
toneal injection at concentrations of approximately 150 μg kg−1 causes difficulty in 
mobilisation, dyspnoea, jumps, tremors and cramps, with all symptoms starting 4 h 
after the injection is given [67, 71, 72].
It is noteworthy that YTX oral administration in mouse did not induce any 
significant difference in haematological and clinical chemistry parameters, includ-
ing leukocyte percentages and plasma levels of alanine-aminotransferase (ALT), 
aspartate aminotransferase (AST), creatine phosphokinase (CPK) or lactate dehy-
drogenase (LDH) [67, 71, 72, 75]. Nevertheless, at an ultrastructural level, changes 
in the myocardium in in vivo studies following both oral and i.p. administration have 
been identified [71, 72, 75–77]. Thus, it has been estimated that YTX intraperitoneal 
administration induces cardiac damage with a potency >10 times greater than the oral 
route [76]. This difference could be related to the low adsorption through the gastroin-
testinal tract and/or biotransformation of toxins associated with the YTX-group [67].
In addition, toxicological data obtained from the evaluation with the YTX and 
homo-YTX analogues have shown that they have approximately the same toxicity 
[64], while the other analogues have lower toxicity, especially OH-YTX and carboxy-
YTX derivatives because they are ≈5 times less toxic than YTX, while other derivatives 
associated with the YTX group, such as trihydroxylated amides (41-a-homo-YTX and 
1,3-enone isomer of heptanor-41-oxo YTX) have shown no toxicity through intraperi-
toneal injections in mice at levels >5000 μg kg−1 body weight [7, 60, 61].
Naturally, the main vectors of the YTX-group correspond to bivalves (endemic 
species) characterised by accumulating large amounts of toxins in their digestive 
glands due to their high filtration capacity. Once they are assimilated and based 
on the chemical modifications caused by bivalves to toxic analogues of YTX, they 
can be spread to other non-visceral tissues such as mantle, gills, foot and adductor 
muscle [62, 74].
The European Food Safety Authority (EFSA) has established that toxic effects 
may even occur at concentrations below 3.75 mg YTX equivalents kg−1 shellfish, 
which is a limit established as an international sanitary standard for marketing 
products [14, 36, 78].
1.1.4 Azaspiracid group (AZA-group)
AZA-group corresponds to toxins produced by toxic dinoflagellates, 
Protoperidinium crassipes, Azadinium spinosum and the sponge, Echinochlathria sp. 
(Table 1) [79–81]. However, in some species it has not been possible to establish 
a direct relationship between the high toxic levels detected in some species of 
endemic bivalves and the cell densities of the dinoflagellates producing this group 
of toxins [82].
The AZA-group has been identified worldwide in molluscs analysed in Ireland, 
United Kingdom, Norway, France, Portugal, North Africa (Morocco), Chile and 
USA (Figure 1) [12, 43, 44, 83].
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To date, ≈24 toxic analogues belonging to the AZA-group have been identified. 
The main toxic analogues detected are: azaspiracid-1 (AZA-1), azaspiracid-2 (AZA-2) 
and azaspiracid-3 (AZA-3) (Figure 5) [84, 85].
The mechanisms of action of the AZA-group have not been clearly determined, 
however studies in vitro in mammalian cells show that they produce alterations in 
the structure of the cytoskeleton of cells and the E-cadherin system, the latter being 
responsible for the interaction between cells [86, 87]. These experimental results 
could explain the symptoms associated with human intoxications such as gastroin-
testinal disorders, abdominal pain and diarrhoea [1]. Although the data obtained 
from seafood extracts have shown that AZAs do not produce diarrhoea [88].
The intraperitoneal lethal dose determined in mice is directly related to the 
toxic analogue detected in shellfish extracts. In this way, AZA-1 has a lethal dose of 
200 μg kg −1, while AZA-2 and AZA-3 are significantly more toxic, with lethal doses 
of 110 and 140 μg kg−1, respectively [28]. In addition, it has been established that 
oral toxicity in mice with AZA-1 at corresponding doses of 900 μg kg−1 produces 
significant damage to the small intestine, while doses of 500 μg kg−1 only produce 
liver damage, which is characterised by an increase in the volume (≈38%) [89, 90].
In addition, toxicological studies have established that the lowest observed 
adverse effect level (LOAEL) for AZAs corresponds to concentrations between 
≈23 and ≈86 μg AZAs kg −1 per person, even though it is estimated that at levels of 
≈80 μg AZA-equivalents kg−1 molluscs would not produce symptoms due to AZA-
group intoxication. However, it has been recorded that when ≈400 g of shellfish 
are consumed, doses corresponding to ≈30 μg AZA-equivalents kg−1 have been able 
to produce AZA-associated intoxication syndrome in humans. These seemingly 
contradictory data can be explained by the variability of toxic forms subjected to 
biotransformation, which produces new and different analogues during the accu-
mulation of toxins in the digestive glands of molluscs [91].
Figure 5. 
Chemical structure of azaspiracid-group and their chemical analogues identified in dinoflagellates and bivalve 
molluscs [79–82].
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Although AZA-1 is the most abundant toxin in this group, the analogues cor-
responding to AZA-2, AZA-3, 8-methyl-AZA-1 and 22-demethyl-AZA-1 frequently 
co-occur in different types of bivalves (Figure 5). The formation of AZA-3 from 
AZA-1 in Mytilus sp. corresponds to a xenobiotic bioconversion, even though this 
detoxification pathway results in the formation of a more toxic analogue [81]. The 
toxicity of molluscs contaminated with AZA-group toxins tends to persist for an 
average period of ≈5 months post-bloom, allowing toxins to be distributed to other 
non-visceral tissue. In some cases, these tissues are able to reach toxic levels superior 
to those described for the digestive glands [12, 92].
In spite of this, the trophic transfer routes through the food web are completely 
unknown, although to date the AZA-group has been detected in other aquatic spe-
cies such as crustaceans [43, 93].
2. Results
2.1 Methods of detection
Each group of toxins (OA, PTX, YTX and AZA) present in the different endemic 
species of bivalves or marine organisms is composed of many toxic analogues, so 
regulatory levels are represented according to the total toxicity of the analogues 
studied. Traditionally, regulatory limits have been evaluated using mouse bioassay 
(MBA), which involves intraperitoneal injection of seafood extracts [14, 91].
Nevertheless, we should consider that one single type of shellfish may contain 
more than one toxic group, therefore, alternative methods to the bioassays are 
required for the detection and proper identification of each analogue that may 
belong to the different described groups [94].
To identify toxic groups, there are also functional tests, which are traditionally 
defined as methods of detection based on the mechanism of action that each toxin 
group has in order to establish its quantification, which, in turn, is related to the 
group toxicity. These assays are usually receptors, proteins or cells [95].
Since shellfish consumption is very important from an economic standpoint, most 
producer and consumer countries have implemented monitoring systems to prevent 
these toxins from reaching consumers [94]. These monitoring systems based on 
detection methods are required to be highly specific, reproducible systems and must 
not be prone to produce either false positives or false negatives [14].
Thus, some countries differ in the selection of the method required for the 
identification of toxin groups and three different methods can be used: biological 
methods (Mouse Bioassay, MBA), biochemical methods (Protein Phosphatase-2a 
Inhibition Assay, PP2aIA) and chemical methods (Liquid chromatography coupled 
with tandem mass spectrometry, LC-MS/MS) [96]. Biological and biochemical 
methods only establish the presence of one group of toxins; they do not identify the 
toxin involved in a mixture of analogues in a process of contamination or associated 
with a HAB whereas chemical methods provide a profile of the quantity and variety 
of analogues in a contaminated sample [94].
At an international level, the identification of LMT has been regulated by 
establishing maximum permissible concentrations for marine organisms destined 
for human consumption. The maximum permissible limits are 160 μg of OA equiva-
lents kg−1 shellfish meat for OA-group, PTX-group and AZA-group; and 3.75 mg of 
YTX equivalents kg−1 shellfish for YTX-group [29, 30, 78].
It is also worth noting that the OA- and PTX-groups are represented toxicologi-
cally together, but this fact is based more on the possible co-occurrence of toxins 




Diagram of the stages required for the determination of OA-group toxins through the use of the mouse bioassay 
(MBA) [95, 98].
it should be considered that these groups do not share the same biological action 
mechanisms [14, 35, 55].
This regulation allows a series of methods for the detection of these groups, noted 
among them, immunoassays, functional tests (inhibition of protein phosphatase) 
and LC-MS/MS [97].
2.1.1 Biological method: mouse bioassay (MBA)
The mouse bioassay (MBA) is a biological assay used for the determination 
of toxins corresponding only to the OA-group. This bioassay can only provide a 
response to this group of toxins, however it does not provide any information on the 
analogues present in contaminated shellfish [7].
To obtain results, this bioassay requires the use of at least three animals per 
sample, which, in the end, are euthanized regardless of the obtained toxicity result 
[95]. Thus, the shellfish extract is injected via intraperitoneal (i.p.) route to three 
male mice that must have a weight ranging between 16 and 20 g. A sample is consid-
ered positive (contaminated with OA-group) when at least two of the three mice die 
within 24 h of the injection (Figure 6) [95, 98].
The positive result of this bioassay on toxic samples causes diarrhoea in mouse, 
which is directly proportional to the concentrations of toxins present in the toxic 
seafood extract. The toxins detected by this MBA may even be present in the 
faeces of the animals when the concentrations are >700 μg kg−1, with an average 
lethality exceeding 30% at a dose of ≥1000 μg kg−1 [34]. Excretion of OA-group 
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toxins through faeces indicates that a fraction of the toxin ingested by animals is 
not absorbed, being eliminated instantaneously, while it is possible to detect low 
levels in different organs (liver, pancreas, and spleen) as compared to the amount 
excreted in urine and faeces [34, 99].
In the absence of death (negative assays), mice may similarly develop symptoms 
specific to OA-group toxins which are significant indicators of a potential contami-
nation and risk [14, 100].
However, a critical factor of the MBA is the body weight of the mouse used, which 
significantly influences the susceptibility of the toxins associated with the OA-group. 
The lethality after inoculation of OA at 24 h post-injection reaches 100% in mouse 
with weights of 14–15 and 16–17 g, while for groups of 19–20 g, it reaches 80% and 
for groups of mouse weighing between 21 and 22 g, it only reaches 50% [98].
Moreover, all toxins in the OA-group have been shown to be less toxic by oral 
route compared to an intraperitoneal injection route. The median lethal dose (LD50) 
via oral route for OA is approximately 400–880 μg kg−1. Specifically, LD50 toxicity 
via i.p. for OA averages between 192 and 225 μg kg−1 [101], while for DTX-1, LD50 
toxicity via i.p. is ≈160 μg kg−1 [102] and for the DTX-3 and DTX-4 analogues, 
the toxicity ranges from ≈352 to ≈600 μg kg−1 [103]. It should be noted that the 
acylated forms (DTX-3, acyl-derivatives-OA-group) can show a decreased toxic-
ity, stating that these toxic analogues can be ≈20 times less toxic than OA [101]. 
Additionally, preliminary data on the oral toxicity of DTX-2 samples showed that 
oral LD50 is ≈2150 μg kg
−1 body weight [104].
These variabilities on acute toxicities of various analogues such as DTX-4 and 
7-O-palmitoyl-OA are related to the bioavailability of toxins within the peritoneal 
cavity, which, at varying ranges, are hydrolysed under acidic or alkaline conditions 
or by the action of esterases or lipases within the gut allowing for the production of 
more toxic forms such as OA or DTX-1 [50, 101, 105].
This toxic variability between different analogues means the use of the MBA has 
a probability of detecting toxins between 40 and 50% associated with the OA-group 
in the currently established limit of 160 μg OA-equivalents kg−1 [7, 10, 14, 102].
Despite the above mentioned, the great advantage of the MBA is that it provides 
an estimate of the total toxicity of the sample [14], but, at the same time, it has 
multiple disadvantages:
• It requires animal facilities and expertise (bioterium).
• It cannot be easily automated due to the involvement of animal handling.
• It has a high variability in the results between laboratories, due to characteristics in 
the mouse used (breed, sex, age, weight, general health status, diet, stress) [98].
• It produces false-positive results due to fatty acid interferences (20,4n-6 and 
20,5n-3) [106].
• It can produce false-negative results due to the toxic suppression between 
groups [96].
• Interfering matrices from heavy metals.
• It is not selective for the OA-group toxins [107].
• It is not a quantitative bioassay and it has a limit of detection ≈200 μg kg−1.
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• The i.p. injection of the sample is not suitable for the complete detection of 
the OA-group, since some analogues require hydrolysis to be detected (acyl-
derivatives) [105].
• Some countries have banned it for ethical reasons.
Within these disadvantages, it has been established that MBA is able to detect 
toxins of the OA-, AZA- and YTX- groups. However, the result will never be able 
to determine the exact group responsible for it, as there is a co-occurrence of these 
toxins in contaminated endemic species (shellfish) [7, 12, 13, 26].
Toxic evaluations in mice related to the YTX-group have shown that they die 
(2/3) by injecting them with doses 0.75 mg YTX kg−1 body weight, while this 
increases (3/3) with a dose of 1 mg YTX kg−1 body weight. However, mice cannot be 
killed with oral doses of 10 mg kg−1 YTX kg−1 body weight (LD50 i.p. ≈100 μg kg
−1) 
[7]. The differences between intraperitoneal and oral toxicities of YTX would prob-
ably be related to the low YTX uptake in the gastrointestinal tract (≈0.02%) [35]; 
those factors are increased when considering other analogues of the YTX-group that 
arise from the processes of biotransformation in the tissues of marine organisms 
(45-hydroxy-YTX, carboxy-YTX) [7].
Regarding the toxic evaluation through MBA with the AZA-group, it has been 
established that this assay is capable of detecting the toxins associated with AZA-
group, producing neurotoxic symptoms in mice such as: slowness, respiratory 
difficulties, spasms, progressive paralysis and death between 20 and 90 min after the 
application of the mouse bioassay. Thus, it has been determined that the minimum 
i.p. lethal dose required to cause swelling of the stomach and liver in the mouse, with 
a reduction in the size and weight of the thymus and spleen is ≈150 μg kg−1 [10].
In addition, it has been established that the different analogues of this group 
have different toxicities, the minimum lethal dose of AZA-2 (8-methyl-azaspiracid) 
and AZA-3 (22-desmethyl-azaspiracid) corresponds to ≈110 and ≈140 μg kg−1, 
respectively, suggesting a higher potency in relation to AZA-1. However, AZA-4 
and AZA-5 are less toxic, with lethal dose values of ≈470 and < 1000 μg kg−1, 
respectively. In this way, the toxicity of these analogues through the MBA can be 
represented as follows: AZA-2 > AZA-3 > AZA-1 > AZA-4 > AZA-5 [10, 16].
In relation to the toxic evaluation of AZA-group by oral route, it has been shown 
that it does not produce death in mice at concentrations >900 μg kg−1 after 24 h. 
However, post-mortem evaluations have shown various gastrointestinal distur-
bances, such as accumulation of fluid from the ileum and necrosis of intestinal 
epithelial cells [10].
For the PTX-group, toxic data related to the MBA establish that they are highly 
toxic by i.p. injection in values averaging between ≈219 and ≈411 μg kg−1 [60], 
which leads to a positive MBA. However, PTXs appear to be of low toxicity by oral 
route (≈5.0 mg kg−1) and, unlike OA, they do not cause diarrhoea, in addition to the 
fact that PTX-group is easily destroyed under basic conditions [60, 108].
In this regard, toxicity in mouse with different combined doses of LMTs by oral 
route has been assessed. Thus, combined oral doses of YTX (1 mg kg−1 day−1) and 
OA (0.185 mg kg−1 day−1) show no lethal effects or diarrhoea or any other symp-
toms of toxicity in mice, as opposed to the results obtained from the toxic evalua-
tion of these groups individually [67].
These data are consistent with the evaluation of combined doses of yessotoxin 
(1.0 or 5.0 mg kg−1) and AZA-1 (200 μg kg−1) given to mice; those doses do not 
produce toxic effects on the heart or any other internal organs. It is noted that the 
absorption of YTX is not potentiated by the co-administration of AZA-1 [67, 109].
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Furthermore, the combined evaluation of OA and AZA-1 shows that there is no 
increase in pathological changes when AZA-1 and OA are administered together, 
if compared to the administration of OA alone, where a jejunal dilatation is clearly 
evidenced. It should be noted the reduction of OA absorption in the internal organs 
when administered together with AZA-1 or vice versa, due to the competence expe-
rienced by the weak organic acids through the simple diffusion of the membranes 
of the gastrointestinal tract should be noted [32].
In conclusion, MBA is not the most appropriate when considering the simulta-
neity of the toxic bloom processes at a global level and the high capacity of biotrans-
formation of shellfish, which would produce a high variability in the toxicity results 
through this bioassay.
2.1.2 Biochemical method: protein phosphatase 2a (PP2a) inhibition assay
Biochemical assays are the preferred methods for detecting LMTs in endemic 
species (shellfish). However, they cannot provide a quantitative measure of all 
toxic groups (OA-, PTX-, AZA- and YTX-group). This is the main problem of the 
protein phosphatase 2a (PP2a) inhibition assay, a recognised biochemical method 
capable of accurately detecting and quantifying only some analogues related to the 
OA-group [96, 107, 110, 111].
The PP2a inhibition assay (PP2aIA) is a rapid method for the detection of toxins 
associated with the OA-group, which is based on its functional property of inhibit-
ing type PP2a (Figure 7) [112–114]. In general, this method tends to be precise, 
sensitive, reproducible, simple, and fast [47, 115, 116].
Figure 7. 




Several methods of purification of PP2a have been proposed, including: puri-
fication of recombinant PP2a overexpressed in insect cells [114, 117, 118], PP2ac 
expression in mammalian cells [119], and overexpression of PP2ac in yeast [120]. 
However, none of these systems is capable of producing a high yield of recombinant 
proteins [110, 121].
The principle of the assay is based on the fact that PP2a reacts with the p-nitro-
phenylphosphate (p-NPP) substrate, which is colourless to produce p-nitrophenol 
(p-NP) by the enzymatic reaction, characterised by having a yellow colour. The 
toxins associated with the OA-group (OA and DTX-1) inhibit the enzyme, causing 
a loss of production of the p-NP; this loss is determined through the variability of 
the absorbance at 405 nm [107]. The amount of enzyme determines the amount of 
analyte (OA and DTX-1) needed for the inhibition, while the quality of the enzyme 
ensures the amount of product formed per time unit [122]. In addition, the lack 
of stability or impurity of the standards used (OA and DTX-1) directly affect the 
quantification [123, 124].
Regarding the OA-group, it should be noted that DTX-1 is a more potent inhibi-
tor of PP2a than OA [125, 126], whereas DTX-2 is half as potent when compared to 
OA [102, 112]. The presence of esters in microalgae, such as DTX-4 is ≈500 times 
less active than OA [103] and acylated forms originated from the biotransformation 
process in shellfish, such as 7-O-palmitoyl-OA, which is a very weak inhibitor of 
PP2a, ≈3000 times less active than OA (Table 2) [101].
Additionally, the sensitivity of the enzymes (PP2a) for the evaluation of toxins 
associated with the OA-group may be drastically different. Thus, the choice of the 
enzyme and the source of origin are crucial for the proper performance of the sys-
tem. Therefore, one of the main drawbacks is related to the low enzymatic stability 
of this assay, so, to overcome this problem, some kits have immobilised the enzyme 
(PP2a), which is a crucial step for the extraction of biosensors [107].
The great advantage of PP2aIA is that it provides an estimate of the total toxicity 
of the sample; it is a repetitive and fast assay [14]. At the same time, the PP2aIA has 
multiple disadvantages, among which, the following are found:
• It requires a good quality enzyme (PP2a) [123, 124].
• It requires background knowledge for the interpretation of data.
• It requires interlaboratory validation and standardised protocols.
Toxins PP2a
Substrate Ki
Okadaic acid (OA) pNPP 30
Dinophysistoxin-1 (DTX-1) pNPP 19








Inhibition of PP2a by OA-group [112, 122, 127].
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• The matrices from marine organisms can underestimate or overestimate the 
results [124, 129].
• It does not provide any information on the profile of OA-group [101].
• It does not detect acyl-derivatives of OA-group directly [126, 128]
• It does not identify analogues associated with the PTX-, YTX- and AZA-groups 
[96, 107].
At present, it is widely accepted that the toxic effects of OA-group are caused 
by the inhibition of protein phosphatases. However, there is no concrete evidence 
supporting this hypothesis. This is because a pathway from inhibition of PP2a to 
the toxic effect produced by toxins in the OA-group has not been identified. The 
OA-group-induced toxic effects are replicated by substances which are not inhibi-
tors of protein phosphatase (Vibrio parahaemolyticus), and known inhibitors of 
protein phosphatase (Microcystin, MC) do not exert the same toxic effects in 
animals just as the OA-group toxins. Therefore, this method does not have a direct 
relationship with the systemic effects involved in the processes of intoxication in 
humans, which are directly limited to the specific ability of the OA-group to inhibit 
PP2a [101].
However, the results of PP2aIA obtained with OA-group toxins are very well 
correlated with the results obtained using the MBA. The IC50 concentrations for 
DTX-2 and OA are ≈5.94 and ≈2.81 ng ml−1, respectively, indicating that OA is 
approximately two times more toxic than DTX-2 [102].
Different origins of PP2a enzymes have allowed for comparisons of the assay, 
demonstrating that PP2a wild-type is significantly more sensitive to all toxins 
in the OA-group, relative to that obtained from a recombinant origin, which is 
≈1.9-fold lower IC50 for OA, ≈1.7-fold lower IC50 for DTX-1, and ≈2.2-fold lower 
IC50 for DTX-2 [124]. Thus, the PP2aIA can be considered to detect toxins associ-
ated with toxins of the OA-group since its limit of detection (LOD) and limit of 
quantification (LOQ ) are <160 μg OA equivalents kg−1 (international maximum 
limit). Nevertheless, its optimal range of toxic detection is very narrow (between 
≈56 and ≈96 μg OA kg−1 shellfish) due to the fact that matrices and pigments of 
bivalves may affect the interpretation of results [14, 123]. It should be considered 
that samples with DTX-2 only are not able to adequately inhibit PP2a. In this way, 
and comparing the different types of enzymes according to their origin, it has been 
generally established that recombinant PP2a tend to underestimate the equivalent 
contents of OA, whereas the tendency of PP2a wild-type is to overestimate the 
toxicities [124].
Moreover, the process to establish the total toxicity of a sample of shellfish 
exposed to HABs associated with OA-group through PP2aIA necessarily involves 
the hydrolysis of the samples from shellfish, in order to establish the ranges of acyl-
derivatives, which are only detected in shellfish and which are also notable for not 
producing a very low inhibition of the different types of PP2a [126, 128]. Thus, the 
acylated analogues must be transformed to their base analogue, which could be OA, 
DTX-1 or DTX-2. This pathway has estimated that the method tends to consider an 
overestimation through the PP2aIA, due to the non-specific inhibition by compo-
nents present in the matrices of different endemic species (bivalves), that even at 
low concentrations (<LOD) produce an effect similar to the inhibition produced by 
OA. This could be related to the presence of some soluble lipids in methanol, which 
exert a non-specific inhibitory effect on PP2a or the interaction between the matrix, 
reagents and/or the temperature step involved in the assay [97, 124, 129].
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Furthermore, the high concentrations of matrix from endemic species (shell-
fish) interfere with the PP2aIA. This is due to the colouring that most of the differ-
ent shellfish matrices have an effect that, without use of appropriate controls, could 
erroneously establish the presence of toxins associated with the OA-group [97, 111].
Another limiting factor with this assay is its storage temperature. This is because 
the substrate is very stable at temperatures <15°C and very sensitive to high tem-
peratures (≥37°C), which may lead to underestimation of toxins related to the 
OA-group. Within this process, it is possible to consider the percentage of recover-
ability from the different matrices, which has been established between ≈70 and 
≈163%, notably affecting the quantification of toxins from shellfish [123].
Finally, one of the biggest disadvantages of PP2aIA is its inability to identify 
toxins or toxic analogues associated with PTX-, AZA- and YTX-groups [121]. 
Thus, PP2aIA is only limited to identify the presence of the toxins associated with 
OA-group, when applicable, even though the co-occurrence of toxins in water or 
shellfish is evident [12, 13, 26]. Therefore, to identify all toxins in the hypothetical 
simultaneous presence of all toxic groups in contaminated shellfish, the specific use 
of enzymatic or cellular assays will be required, considering also that they will never 
be able to identify the analogues involved in the toxic event accurately [7, 10].
In conclusion, this assay does not tend to be the most adequate to consider the 
simultaneity of processes of toxic blooms at a global level, in addition to the fact it 
is not able to provide any information on the profile of the toxins involved in the 
bloom or contamination of the endemic species (shellfish), which is a crucial stage 
if we consider that it is the basis of the information in the establishment of risk 
assessment and management [7].
2.1.3 Chemical method: liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS)
The emergence of instrumental analytical methods for the detection of LMTs 
responds to the different questions regarding the MBA and PP2aIA. Liquid chro-
matography coupled with tandem mass spectrometry (LC-MS/MS) is one of the 
methods that has been highlighted in the last 15 years [130]. This method allows 
for the quantification of all analogues associated with LMTs (OA-, PTX-, AZA- and 
YTX-group) when compared to a certified standard for toxins (Figure 8) [7, 104].
This chemical method (LC-MS/MS) has been validated and approved by the 
European Regulation as the new official method for the control of LMTs in shellfish 
[29, 78, 107, 131]. However, the quantification of toxin analogues is not sufficient for 
the control and regulatory decision making, since the different analogues have differ-
ent toxic potencies. For this evaluation, it is necessary to know the relative toxicities of 
the components making up the mixture of toxins present in a contaminated matrix. 
For this reason, the term Toxicity Equivalency Factors (TEFs) has been applied, which 
is defined as the toxicity ratio of a compound from a chemical group that shares the 
same mode of action of a reference compound in the same group [14, 94, 95, 104].
Thus, the establishment of TEFs in alternative methods to the MBA and PP2aIA 
for the detection of marine toxins allows, to a great extent, better protection of the 
consumer in the surveillance programs, since the toxic potential in a mixture of 
toxins in different endemic species and biological matrices can be better estimated 
[94, 97, 102, 104].
In this way, the toxin content detected in the different endemic species matrices is 
expressed as the sum of the equivalents established for each group, considering that 
for the case of the OA-group, it is necessary to estimate the concentrations of esteri-
fied toxins present in the matrices (DTX-3 and acyl-derivatives toxins), a process that 
requires the evaluation of post-hydrolysis samples of the extract from each matrix [14].
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LC-MS/MS is a method 10 times more sensitive (LOD ≈ 3.0 μg kg−1) than 
the known 9-anthryldiazomethane (ADAM) fluorescence method (LOD of 
≈30 μg kg−1), a chemical method that was initially used to determine OA-group 
toxins [132, 133] and then proposed to determine toxins of the AZA-group 
[134]. Nevertheless, for both cases, laborious derivatization steps that increase 
uncertainty in the analysis process are required. In addition, the ADAM reagent 
is unstable and should be stored at low temperatures (≤4°C), because its decom-
position may induce an incomplete derivatization, interfering with the final 
analysis [107].
For the use of this analytical chemical method (LC-MS/MS), it is recommended 
that the analysis of LMTs is started with an initial weight of 150 g of shellfish (with-
out shells), which corresponds to approximately 20–30 bivalves, in order to ensure a 
representative sample is evaluated [14].
The main advantages of the method include the following [7, 10, 14, 40, 96]:
It is highly specific and sensitive.
• It can individually classify and quantify all toxins of LMTs.
• It provides information on the profiles of all LMTs in the samples.
• It can be automated.
• It provides a reproducible interpretation of the results obtained from the analysis.
Figure 8. 
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) for the detection of lipophilic 




LC-MS/MS Parameters for determination of lipophilic marine toxins [14, 40, 46, 113, 131, 136, 137]. *The TEF 
of the hydrolysis product of OA, DTX1 or DTX2 would apply [104].
• It has no ethical restrictions.
The main disadvantages of the LC-MS/MS method include the following:
• It requires costly equipment and highly trained personnel.
• It requires a wide range of reference standards for identification and quantification.
• The different biological matrices (endemic species) can produce problems in the 
interpretation of data.
It should be noted that as of July 2011, Regulation (EU) N0. 15/2011 amended 
the Regulation (EC) No. 2074/2005 in relation to the recognised testing methods 
for the detection of LMTs in live bivalve molluscs, which establishes the LC-MS/MS 
method as the official reference method for the detection of LMTs and their use as 
a routine matter, both for the purposes of official controls at any stage of the food 
chain, and for the self-controls established by food business operators [29, 30, 78].
All the above mentioned considerations have been established by most countries 
to improve their quality controls in water and in bivalves from culture centres or 
endemic species, including water analysis in the location where these cultures are 
carried out. It should be taken into consideration that the dinoflagellates producers 
of OA- and/or PTX-, AZA- and YTX-groups at concentrations of ≈2000 cells L−1 
allow for an adequate accumulation of toxins in bivalves, allowing for the fact that 
they can be toxic. However, the LOD (sensitivity) of the bioassays for the OA-group 
in molluscs corresponds to ≈200 μg kg−1 shellfish, a value above the internationally 
established standard of 160 μg OA equivalents kg−1 shellfish meat [40].
For the evaluation of all LMTs, the chemical method requires each group to be 
evaluated in different ionisation modes (Table 3) [12, 130, 131, 135].
These ionisation modes allow for the obtainment of suitable ionic fragments and 
characteristics of each toxic analogue, which allows for the optimal identification of 
them (Figure 9). Nevertheless, it is possible to use both ionisation modes (positive 
and/or negative mode) for the detection of toxins, but this affects three important 
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factors: sensitivity, intensity in the detection of analogues and formation of struc-
tural fragments generated by the original toxin, producing a difficult interpretation 
of the toxic analogues present in the matrices [97, 138]. Thus, the determination 
of the YTX-group in positive mode produces a very low sensitivity of the ions 
obtained ([M−2Na + 3H]+) making its practical use unfeasible. While in the case 
of OA-group, the evaluation of post-hydrolysis matrices in positive mode tends to 
produce matrix effects that do not allow adequate quantification of toxins related to 
acyl derivatives [139]. In addition, when the base analogues of the OA-group (OA, 
DTX-1 and DTX-2) are evaluated, the primary ions, through a positive ionisation, 
tend to always produce a greater variability, resulting in an overestimation of toxic-
ity under this ionisation mode [7].
Another important factor is the mobile phase to be used. Mobile phases modified 
with different weak carboxylic acids (formic acid, acetic acid, propionic acid and 
n-butyric acid) may, in some cases, (formic acid) result in decreased electrospray ioni-
sation (ESI) responses of the negative ions produced from toxins. This is consistent 
with the idea that acidic conditions decrease the negative-ion ESI response, i.e., the 
conditions at a low pH do not favour the formation of deprotonated analytes [140].
Given the high variability according to the evaluation from different marine 
matrices in different endemic species of the world, it is necessary to consider the 
following validation parameters: accuracy, trueness, precision, linearity, robust-
ness, calibration curve check, limit of detection (LOD), limit of quantification 
(LOQ ), and blank quality control [141–143].
Figure 9. 
Mass/mass spectra obtained from a mixture of analytical standards for determination in negative ion mode: 




The use of any of the established methods should always consider the variable 
clearance rates associated with each potentially toxic marine species; those param-
eters are species-specific in endemic species, since neither body size nor age play a 
decisive role in the clearance rate of toxins [96]. Hence, it is extremely important to 
determine all the groups associated with LMTs.
Moreover, the variability of the results obtained with any of the indicated 
methods is always conditioned to the following parameters:
Growth conditions: The origin of shellfish from endemic species, on the seabed 
or from cultures, subtidal or intertidal growth, water depth, and water column 
mix [7].
Clearance rate: Feeding status, species-specific filtration rates and selectivity, as 
well as the species of microorganisms that can affect endemic species (bacteria and 
pathogenic viruses) [12, 26].
Metabolism/detoxification: Species-specific differences in endemic species, 
metabolic changes in bivalves due to seasonal variation, reproductive status and 
environmental stress [13].
Thus, in order to ensure seafood safety and minimise potential risks to human 
health, the development of rapid, sensitive and reliable methods to detect different 
groups in a preventive manner has been proposed. However, two important factors 
must be considered:
1. Biological and biochemical methods only allow for the detection of specific 
groups of toxins, and may exclude some, which may cause a potential toxicity 
when consuming shellfish seemingly free of toxins [14, 102].
2. EFSA has proposed the reduction of maximum limits of all LMTs associated 
groups, from 160 μg kg −1 to 45 μg OA equivalents kg−1 (OA-Group); 30 μg 
AZA equivalents kg−1 (AZA-group) and 120 μg PTX equivalents kg−1 (PTX-
group); these new limits could only be detected completely by using the 
LC-MS/MS method [7, 14, 107].
4. Conclusions
The above shows that the MBA and PP2aIA assays for LMTs detection cannot 
be effectively used to follow the toxic variability in molluscs or endemic species 
in a quantitative manner, including their detoxification stage, as these assays do 
not allow producers (shellfish growers) to evaluate the results obtained in order 
to plan their production activities adequately and in advance, since the use of 
these assays as screening would have less specificity and a higher cost if compared 
to the confirmation method (LC-MS/MS) used by marine product importing 
countries.
The LC-MS/MS method does not show any ambiguous results, since it solves and 
determines the toxic profiles in different toxic marine endemic species (matrices). 
In addition, it allows for the exact quantification of each group of toxins by keeping 
those samples under the established legal limits in the market, which by using other 
methods could prove to be positive (MBA) or not to be able to establish the toxic 
group involved in a HABs or toxic processes in shellfish (PP2aIA). Thus, the great 
advantage of LC-MS/MS is the possibility of differentiating toxins belonging to 
the OA-, YTX-, AZA and PTX- groups, allowing for the evaluation of the potential 
health risks through the consumption of shellfish.
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